生物反与心理治疗相结合对功能性便秘的作用,并与焦虑和抑郁症相复杂
Zhou Hongyu1, Liao Nana1, Han Mingwei1
1Department of Gastroenterology, 922th Hospital of Joint Logistic Support Force, Hengyang, 421002, China.
Applied psychophysiology and biofeedback
|November 21, 2024
概括
生物反与心理治疗相结合,显著改善了功能性便秘,焦虑和抑郁. 这种治疗也提高了睡眠质量,为患者提供了安全有效的选择.
科学领域:
- 胃肠病学和精神病学 在
背景情况:
- 功能性便秘通常与焦虑和抑郁障碍同时发生.
- 生物反和心理治疗是这些疾病的潜在治疗干预措施.
研究的目的:
- 为了验证生物反与心理治疗相结合的治疗疗效,在功能性便秘,焦虑和抑郁障碍患者中.
- 为了比较这种联合疗法的效果与接受标准药物治疗的对照组.
主要方法:
- 120名患者被随机分配到对照组 (药物) 或治疗组 (药物加生物反和心理治疗).
- 治疗组每天两次接受生物反7天,并在2个月内接受心理治疗.
- 调整了药物剂量,并在6个月内评估了症状得分.
主要成果:
- 两组都表现出改善,但治疗组在便秘,焦虑和抑郁症状方面表现出明显更大的改善.
- 治疗组在第六个月前显著减少了匹兹堡睡眠质量指数 (PSQI) 的得分.
- 结合疗法被发现是持久的,安全的,易于实施的.
结论:
- 生物反与心理治疗相结合是一种有效的治疗方法,可以改善功能性便秘患者的临床症状,焦虑/抑郁状态和睡眠质量.
- 综合方法提供了一个安全,持久且易于实施的治疗选择.
- 这种综合治疗策略显示出广泛临床应用的前景.
相关概念视频
Behavior Therapy
43
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
43
Irritable Bowel Syndrome III: Medical and Nursing Management
169
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
169
Drugs for Treatment of Constipation-Predominant IBS
134
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
134
Cognitive Therapy
145
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
145
Modeling in Therapy
49
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
49
Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147


